First Trust Emerging Markets AlphaDEX Fund ...

First Trust Emerging Markets AlphaDEX Fund (FEM) Hits 52-Week High — Is FEM Still a Buy?

First Trust Emerging Markets AlphaDEX Fund (FEM) hit a 52-week high on NASDAQ. Get trading details, emerging markets risks, and buying considerations now.

Shares of the First Trust Emerging Markets AlphaDEX Fund (FEM) jumped to a new 52-week high during Wednesday trading, drawing renewed attention from income and growth investors. Intraday, FEM traded as high as $32.98 before settling lower; the last reported trade was $30.42, following a prior close of $30.29. Trading volume on the move reached about 32,800 shares.

A 52-week high often signals renewed investor confidence, and for FEM that could reflect optimism about a rebound in emerging markets or growing interest in the fund’s AlphaDEX stock-selection strategy. The intraday peak near $32.98 shows there is demand at higher price points, but the narrower gap between the last trade and prior close suggests the run-up was measured rather than frenzied.

What to consider: First, understand what drives FEM’s performance. Emerging markets can offer higher growth potential than developed economies, but they also bring greater volatility, currency risk, and sensitivity to global trade and commodity cycles. FEM’s AlphaDEX methodology attempts to select stocks based on quantitative factors that can outperform cap-weighted indexes, which may appeal to investors seeking active, rules-based exposure rather than passive index tracking.

Second, evaluate trading volume and liquidity. A volume of 32,800 shares during the high is moderate — enough to signal interest but not necessarily indicative of a sustained institutional buying wave. Investors should check current bid-ask spreads and the fund’s structure (ETF or closed-end vehicle) to understand how liquidity could affect entry and exit costs.

Third, align FEM with your investment goals and risk tolerance. Emerging markets exposure can diversify a portfolio, but it’s best suited for investors with a longer time horizon who can tolerate periodic drawdowns. Before buying, review FEM’s holdings, expense ratio, dividend distribution policy, and tax considerations.

Bottom line: FEM’s new 52-week high is a noteworthy development, yet it shouldn’t be the sole reason to buy. Use the uptick as a prompt to do deeper research into the fund’s strategy, costs, and how it fits into your overall portfolio. This article is informational and not investment advice; consult a financial advisor to determine if FEM is appropriate for your situation.

Back